Patenting antibody combination therapies

There is emerging, intense interest in antibody combination therapies. However, antibody combination therapies pose unique intellectual property challenges. In some instances, it may be difficult to obtain patents with claims that provide innovators with adequate protection for such inventions. Pate...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Li, Chen, Lin, Murphy, Amanda, Jacobstein, Jeffrey, Lewis, Stacy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990264/
https://www.ncbi.nlm.nih.gov/pubmed/33928232
http://dx.doi.org/10.1093/abt/tbaa026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990264/
https://www.ncbi.nlm.nih.gov/pubmed/33928232
http://dx.doi.org/10.1093/abt/tbaa026

Ejemplares similares